MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
BAUSCH HEALTH COS INCCA2.88%
NOVARTIS AG-ADRCH5.25%
NOVO-NORDISK A/S-SPONS ADRDK4.08%
SANOFI-ADRFR5.26%
AMARIN CORPORATION PLC -ADRGB0.52%
ASTRAZENECA PLC-SPONS ADRGB5.28%
GLAXOSMITHKLINE PLC-SPON ADRGB4.58%
JAZZ PHARMACEUTICALS PLCIE2.82%
PERRIGO CO PLCIE1.47%
TEVA PHARMACEUTICAL-SP ADRIL3.69%
TAKEDA PHARM-ADRJP4.54%
MYLAN NVNL5.13%
ELI LILLY & COUS4.82%
ELANCO ANIMAL HEALTH INCUS3.19%
ABBVIE INCUS5.29%
MERCK & CO. INC.US5.34%
AMERISOURCEBERGEN CORPUS4.79%
BRISTOL-MYERS SQUIBB COUS5.43%
PATTERSON COMPANIES INCUS0.60%
MCKESSON CORPUS4.84%
ORGANON & COUS2.91%
CATALENT INCUS3.49%
ZOETIS INCUS3.83%
PFIZER INCUS5.09%
JOHNSON & JOHNSONUS4.87%
Items 1-25 of total 25
Up